PHAS-I is the first member of a newly discovered family of proteins that regulate the rate-limiting step in translation initiation and that appear to be key mediators of the effects of hormones and growth factors on protein synthesis. Recent evidence suggests that PHAS-I is involved in mitogenic control; and, in preliminary experiments overexpressing PHAS proteins in ras-transformed fibroblasts markedly decreased cell proliferation and promoted reversion to a normal phenotype. The major objective of this proposal is to investigate the regulation and function of this important family, PHAS-I & -II bind to eIF-4E, the mRNA cap binding protein, and inhibit translation in vitro and in cells. Phosphorylation of PHAS-I in response to insulin or growth factors causes dissociation of PHAS-I and eIF-4E, allowing eIF-4E to participate in translation initiation. Rapamycin or increasing cAMP promotes PHAS-I dephosphorylation and increases binding to eIF-4E. PHAS-II is highest in tissues where PHAS-I is lowest. Unlike PHAS-I, PHAS-II is readily phosphorylated by PKA, suggesting that regulation of the two proteins differs. We propose to investigate the signaling mechanisms involved in regulating the proteins. Their phosphorylation in response to agents that regulate association with eIF-4E will be characterized. Peptide mapping and site-directed mutagenesis will be used to identify important phosphorylation sites. Bicistronic mRNAs that allow assessment of cap- dependent protein synthesis will be used to investigate the effects of PHAS proteins on translation in vitro and in cells. Secondary structure will be introduced into the 5'-UTR to investigate the hypothesis that the inhibitory effect of PHAS proteins on translation is greatest with mRNAs that are most dependent of eIF-4E for initiation. Wildtype and phosphorylation-site mutants of PHAS proteins will be introduced into cells by transient expression, microinjection, and stable transfection to investigate the role of PHAS-I & -II in mediating the actions of insulin and growth factors on translation initiation, protein synthesis, and cell proliferation. The diversity of the family will be investigated by attempting to identify new PHAS proteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK052753-02
Application #
2458953
Study Section
Biochemistry Study Section (BIO)
Program Officer
Margolis, Ronald N
Project Start
1996-09-21
Project End
2000-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Virginia
Department
Pharmacology
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Glidden, Emily J; Gray, Lisa G; Vemuru, Suneil et al. (2012) Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein. J Biol Chem 287:581-8
Harris, Thurl E; Finck, Brian N (2011) Dual function lipin proteins and glycerolipid metabolism. Trends Endocrinol Metab 22:226-33
Kumar, Anil; Lawrence Jr, John C; Jung, Dae Young et al. (2010) Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes 59:1397-406
Liu, Guang-Hui; Qu, Jing; Carmack, Anne E et al. (2010) Lipin proteins form homo- and hetero-oligomers. Biochem J 432:65-76
Blancquaert, Sara; Wang, Lifu; Paternot, Sabine et al. (2010) cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4. Mol Endocrinol 24:1453-68
Kim, Hyun Bae; Kumar, Anil; Wang, Lifu et al. (2010) Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors. Mol Cell Biol 30:3126-39
Gropler, Matthew C; Harris, Thurl E; Hall, Angela M et al. (2009) Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in mice. J Biol Chem 284:6763-72
Wang, Lifu; Lawrence Jr, John C; Sturgill, Thomas W et al. (2009) Mammalian target of rapamycin complex 1 (mTORC1) activity is associated with phosphorylation of raptor by mTOR. J Biol Chem 284:14693-7
Sturgill, Thomas W; Hall, Michael N (2009) Activating mutations in TOR are in similar structures as oncogenic mutations in PI3KCalpha. ACS Chem Biol 4:999-1015
Chen, Zhouji; Gropler, Matthew C; Norris, Jin et al. (2008) Alterations in hepatic metabolism in fld mice reveal a role for lipin 1 in regulating VLDL-triacylglyceride secretion. Arterioscler Thromb Vasc Biol 28:1738-44

Showing the most recent 10 out of 31 publications